Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com
Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Read more

Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2020

Published by Statista Research Department, Feb 12, 2021
In fiscal year 2020, Aurobindo Pharma's net debt to EBITDA ratio was 0.56, down from fiscal year 2019. The net profit of the pharmaceutical company before taxes was over 28 billion Indian rupees in financial year 2020.

Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account
$39 $59 per month *
in the first 12 months
View for free
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Additional Information

© Statista 2021

Show source

Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

August 2020

Region

India

Survey time period

FY 2013 to FY 2020

Supplementary notes

EBITDA refers to earnings before interest, tax, depreciation and amortization. Financial analysts use the net debt to EBITDA ratio to determine a company’s ability to pay its debt. A high ratio of net debt to EBITDA reveals a company that is deep in debt and vice versa for a low ratio.

*Includes higher sales from limited competition product.

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "GlaxoSmithKline Pharmaceuticals Limited India"

The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.PfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu